(voir la traduction en français en dessous du communiqué)
WHO invites you to participate in a public consultation on the scope of its guideline on ensuring balanced national policies for access and safe use of controlled medicines. Additional information on this guidance document including a proposed scope and list of guideline development group members may be found at the following link:
https:// who.int/medicines/access/controlled-substances/controlled_medicines_access/en/
This document is a revision of the 2011 WHO guidance document "Ensuring balance in national policies on controlled substances: Guidance for availability and accessibility of controlled medicines." The new guideline will assist policy makers as well as programme managers and experts in countries in the formulation and implementation of balanced policies to ensure access to and safe use of controlled medicines while preventing their diversion, misuse and harm to health.
As part of the revision of this document, WHO is carrying out an online public hearing on the scope of the guideline on 19 February 2020 at 14:00 CET. Additional information on how to register for this public hearing can be found at the link above . The deadline to register interest in submitting a written or oral statement at the public hearing is 11 February.
For any further queries, please contact
controlled.medicines@who.int